Skip to main content

Table 1 The MICs of glutaraldehyde in clinical isolates during 1991–2000.

From: Synergistic effect of imp/ostA and msbA in hydrophobic drug resistance of Helicobacter pylori

Disease Number of isolates The MICs of glutaraldehyde in isolates (numbers)
Gastritis 15 7 μg/ml (n = 2), 6 μg/ml (n = 1)
5 μg/ml (n = 3), 4 μg/ml (n = 4)
3 μg/ml (n = 5)
Duodenal ulcer 16 10 μg/ml (n = 1), 7 μg/ml (n = 1)
6 μg/ml (n = 2), 5 μg/ml (n = 3)
4 μg/ml (n = 5), 2 μg/ml (n = 2)
1.5 μg/ml (n = 1), 1 μg/ml (n = 1)
Gastric ulcer 9 10 μg/ml (n = 1), 7 μg/ml (n = 1)
6 μg/ml (n = 3), 5 μg/ml (n = 1)
3 μg/ml (n = 1), 1.5 μg/ml (n = 1)
1 μg/ml (n = 1)
MALToma 3 7 μg/ml (n = 1), 5 μg/ml (n = 2)
Gastric cancer 6 6 μg/ml (n = 3), 5 μg/ml (n = 1)
3 μg/ml (n = 2)